Back to search

Peptide record

TPDB21206

Antibacterial Anticancer Antiviral Toxicity modified_plain modified
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB21206
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia dbAMP 3.0
modified_plain
Yes
A 37-aa modified multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia and dbAMP 3.0, with an available 3D structural model.
Modified, details unspecified
Sequence
IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXK
Physicochemical Analysis
C201H354N52O62
ARNDCGHLMFPSTWYV
K
4491.33
9.33
11
10
10
+1
30.89
-1.362
105.41
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
5
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
10
E
5
Q
0
G
0
H
10
I
0
L
11
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 10 Q: 5 G: 0 H: 0 I: 10 L: 0 K: 11 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
37
C201H354N52O62
4491.33
9.33
+1
30.89
-1.362
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>100 µM
Cytotoxic
50% Cytotoxicity | >100 | µM | target cell: Madin-Darby canine kidney cells

Target

Madin-Darby canine kidney cells

Source & Reference

NA
DBAASP
De Novo Design of alpha-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. | J Med Chem | 2018
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
J Med Chem. 2018 Oct 11 61(19):8734-8745.